Summary
Splenocytes from parous rats have been previously found to have cytotoxic activity against mammary tumor cells in vitro. Experiments were carried out to determine if this pregnancy-induced cytotoxic nature of the splenocytes is inherent and transferable. Splenocytes from parous rats were adoptively transferred to a group of virgin rats. Another group of age-matched, virgin rats received splenocytes from virgin donors in a similar way. After a period of rest, at the age of 55 days, the rats belonging to both of the groups, received 7,12-dimethylbenz(a)anthracene (DMBA) intragastrically. A third group of untreated virgin rats were also given the chemical carcinogen the same way as above and were considered as intact controls. The rats were monitored for development and growth of mammary tumor from 60 days of DMBA administration. After 4 months of DMBA administration the rats were sacrificed and mammary glands were examined for tumors. Mammary glands with no visible tumors were taken for whole mount preparation, to be examined for microscopic lesions. The results showed that 33 of 41 intact control rats, developed tumor and 27 of the 34 rats that received spleen cells from virgin rats developed tumors. Of the rats that received spleen cells from parous rats, only 18 out of 37 rats developed tumors, indicating an inhibition of tumor induction in these rats. Growth rate of the tumors in this group was also slower than in the control groups.
Similar content being viewed by others
References
Brenner RD, Nisbet AD, Herriot R, Horne CHW, McArdle C, Crawford D, Bohn H (1981) Detection of Placental Protein Five (pps) and Pregnancy Specific Glycoprotein (SPI) in Benign and Malignant Breast Disease. Onco Develop Biol Med 2: 55
Chakravarty PK, Ghosh SK, Sinha DK (1991) Pregnancy-induced cytotoxicity of splenocytes against mammary tumor cells in rat. Oncology (in press)
Crawford V, Pim DC, Bulbrook RD (1982) Detection of antibodies against the cellular protein P53 in sera from patients with breast cancer. Cancer 30: 403
Crum ED (1980) Lymphocytes that mediate systemic resistance to in vivo growth of a carcinogen-induced syngenic tumor. Int J Cancer 26: 53
Dao TL, Pazik J (1981) Early pregnancy protects against mammary gland carcinogenesis. Proc Am Assoc Cancer Res 22: 96
Durie BGM, Salmon SE (1975) High speed scintillation autoradiography. Science 190: 1093
Forsman LM, Jouppila PI, Andersson LC (1984) Sera from multiparous women containing antibodies mediating cytotoxicity against breast carcinoma cells. J Immunol 19: 135
Corcznski RM (1978) Response of tumor-related and normal lymphocytes to antigen on fibroblasts from embryos of varying age. Br J Cancer 37: 780
Gorcznski RM, MacRae S (1982) Retardation and promotion of growth of spontaneous by appearing tumors using immune lymphocytes previously exposed to embryonic antigens. Cancer Res 42: 784
Grudzinska J, Coombes R, Ratcliffe JG, Gordon YB, Powles TJ, Munro Neville A, Chard T (1980) Circulating levels of pregnancy specific A-1 glycoprotein in patients with testicular, Bronchogenic and breast carcinomas. Cancer 45: 102
Haller O, Hansson M, Kiessling R, Wigzell H (1977) Role of nonconventional natural killer cells in resistance against syngeneic tumor cells in vivo. Nature 270: 609
Herberman RB, Holden H (1978) Natural cell mediated immunity. Adv Cancer Res 27: 305
Kiessling R, Wigzell H (1979) An analysis of the murine NK cells as to structure, function and biological relevance. Immunol Rev 44: 165
Kuperman O, Fortner GW, Lucas ZJ (1975) Immune response to a syngeneic mammary adenocarcinoma III. Development of memory and suppressor functions modulating cellular cytotoxicity. J Immunol 115: 1282
Monteiro J, Biswass Al-Awquati MA, Greening WP, McKinn JA, Neville AM (1982) Serum levels of human placental lactogen and pregnancy-specific Al glycoprotein in breast cancer. Br J Cancer 46: 279
Moore DH, Moore DH 2nd, Moore CT (1983) Breast carcinoma etiological factors. Adv Cancer Res 40: 189
Rhodes HM, Overall JE (1982) Quantitative methods. Psychol Bull 91: 418
Russo J, Russo IH (1980) Susceptibility of the mammary gland to carcinogenesis: II. Pregnancy interruptions a risk factor in tumor incidence. Am J Pathol 100: 497
Russo J, Russo IH (1987) Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112
Sarcione EJ, Dellumo D, Zloty M (1983) Pregnancy associated alpha-2 glycoprotein (PAG) synthesis by human breast cancer tissue and cultured cell lines. Int J Cancer 31: 143
Sinha DK (1981) Growth of mammary glands from monodisperesed cells and susceptibility to 7,12-dimethylbenz[a]anthracene. Cancer Lett 12: 111
Sinha DK, Pazik JE, Dao TL (1988) Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Br J Cancer 57: 390
Warner NL, Woodruff MFA, Burton RC (1977) Inhibition of the growth of lymphoid tissue in syngeneic athymic (nude) mice. Int J Cancer 20: 146
Author information
Authors and Affiliations
Additional information
This research was supported by USPHS grant CA 3613906 awarded by the National Cancer Institute
Rights and permissions
About this article
Cite this article
Chakravarty, P.K., Sinha, D.K. Inhibition of mammary tumorigenesis in virgin rats by adoptive transfer of splenocytes from parous donors. Cancer Immunol Immunother 33, 263–266 (1991). https://doi.org/10.1007/BF01744946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01744946